CIK 0001157601
- Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 267-824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $35,023,032
- in 1 filing
- Open-market sales, last 90 days
- $6,669,998
- in 2 filings, $6.7M under 10b5-1 plans
Net +$28,353,034. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-07-22 | Schor Chen Former President and CEO | Grant or award | +42,857 | 51,428 | ||
| 2016-07-22 | Schor Chen Former President and CEO | Shares withheld for taxes | −14,250 | $9.48 | $135K | 37,178 |
| 2015-10-02 | Schor Chen President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2015-09-16 | Schor Chen President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +500,000 | 500,000 | ||
| 2015-06-05 | Schor Chen President and CEO | Grant or award | +150,000 | 300,000 | ||
| 2015-06-05 | Schor Chen President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +500,000 | 500,000 | ||
| 2014-12-08 | Schor Chen Executive VP and COO | Grant or award | +150,000 | 150,000 | ||
| 2014-12-08 | Schor Chen Executive VP and COO | Grant or award · Employee Stock Option (Right to Buy) | +450,000 | 450,000 |
Page 1 of 1 · 8 trades